Terms: = Ovarian cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Diagnosis
15 results:
1. Clinico-genomic Characterization of ATM and HRD in Pancreas cancer: Application for Practice.
Park W; O'Connor CA; Bandlamudi C; Forman D; Chou JF; Umeda S; Reyngold M; Varghese AM; Keane F; Balogun F; Yu KH; Kelsen DP; Crane C; Capanu M; Iacobuzio-Donahue C; O'Reilly EM
Clin Cancer Res; 2022 Nov; 28(21):4782-4792. PubMed ID: 36040493
[TBL] [Abstract] [Full Text] [Related]
2. Engineering adoptive T cell therapy to co-opt fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy.
Anderson KG; Oda SK; Bates BM; Burnett MG; Rodgers Suarez M; Ruskin SL; Greenberg PD
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35264436
[TBL] [Abstract] [Full Text] [Related]
3. The effect of fertility-sparing surgery on sexuality and global quality of life in women with malignant ovarian germ cell and sex cord stromal tumors: an analysis of the CORSETT database of the AGO study group.
Hasenburg A; Plett H; Krämer B; Braicu E; Czogalla B; Bossart M; Singer S; Mayr D; Staebler A; du Bois A; Kommoss S; Link T; Burges A; Heitz F; Keul J; Trillsch F; Harter P; Wimberger P; Buderath P; Klar M
Arch Gynecol Obstet; 2021 Dec; 304(6):1541-1549. PubMed ID: 34287678
[TBL] [Abstract] [Full Text] [Related]
4. The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: An Israel gynecologic oncology group study.
Namazov A; Gemer O; Helpman L; Hag-Yahia N; Eitan R; Raban O; Vaknin Z; Leytes S; Lavie O; Amit A; Levy T; Volodarsky M; Ben Shachar I; Atlas I; Bruchim I; Ben-Arie A
Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():120-124. PubMed ID: 31689674
[TBL] [Abstract] [Full Text] [Related]
5. Association of Breast and ovarian cancers With Predisposition Genes Identified by Large-Scale Sequencing.
Lu HM; Li S; Black MH; Lee S; Hoiness R; Wu S; Mu W; Huether R; Chen J; Sridhar S; Tian Y; McFarland R; Dolinsky J; Tippin Davis B; Mexal S; Dunlop C; Elliott A
JAMA Oncol; 2019 Jan; 5(1):51-57. PubMed ID: 30128536
[TBL] [Abstract] [Full Text] [Related]
6. Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas.
Sett A; Borthakur BB; Bora U
Clin Transl Oncol; 2017 Aug; 19(8):976-988. PubMed ID: 28224267
[TBL] [Abstract] [Full Text] [Related]
7. A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial ovarian cancer.
Zhu T; Gao W; Chen X; Zhang Y; Wu M; Zhang P; Wang S
Int J Gynecol Cancer; 2017 Jan; 27(1):3-10. PubMed ID: 27636713
[TBL] [Abstract] [Full Text] [Related]
8. CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma.
Nymoen DA; Holth A; Hetland Falkenthal TE; Tropé CG; Davidson B
Mol Cancer; 2015 Feb; 14():44. PubMed ID: 25889687
[TBL] [Abstract] [Full Text] [Related]
9. The sooner the better: Genetic testing following ovarian cancer diagnosis.
Fox E; McCuaig J; Demsky R; Shuman C; Chitayat D; Maganti M; Murphy J; Rosen B; Ferguson S; Randall Armel S
Gynecol Oncol; 2015 Jun; 137(3):423-9. PubMed ID: 25868966
[TBL] [Abstract] [Full Text] [Related]
10. Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis.
Sørensen SS; Mosgaard BJ
Dan Med Bull; 2011 Nov; 58(11):A4331. PubMed ID: 22047929
[TBL] [Abstract] [Full Text] [Related]
11. Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases.
Capper D; Berghoff AS; Magerle M; Ilhan A; Wöhrer A; Hackl M; Pichler J; Pusch S; Meyer J; Habel A; Petzelbauer P; Birner P; von Deimling A; Preusser M
Acta Neuropathol; 2012 Feb; 123(2):223-33. PubMed ID: 22012135
[TBL] [Abstract] [Full Text] [Related]
12. Reproduction rates after cancer treatment: experience from the Norwegian radium hospital.
Cvancarova M; Samuelsen SO; Magelssen H; Fosså SD
J Clin Oncol; 2009 Jan; 27(3):334-43. PubMed ID: 19075285
[TBL] [Abstract] [Full Text] [Related]
13. Gene expression profile differences in high and low metastatic human ovarian cancer cell lines by gene chip.
Xu S; Mou H; Lü G; Zhu C; Yang Z; Gao Y; Lou H; Liu X; Cheng Y; Yang W
Chin Med J (Engl); 2002 Jan; 115(1):36-41. PubMed ID: 11930655
[TBL] [Abstract] [Full Text] [Related]
14. Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival.
Gansler TS; Hardman W; Hunt DA; Schaffel S; Hennigar RA
Hum Pathol; 1997 Jun; 28(6):686-92. PubMed ID: 9191002
[TBL] [Abstract] [Full Text] [Related]
15. [Magnetic resonance tomography in oncologic gynecology].
Dudarev AL; Vinokurov VL; Shelkoplias EN; Goritskaia IV
Vestn Rentgenol Radiol; 1993; (5):14-5. PubMed ID: 7801576
[TBL] [Abstract] [Full Text] [Related]
